Subject description Immuno-oncological treatment methods have revolutionized cancer therapy in recent years, based on the tremendous effects seen in some patients. The subject/research focus of this position is to develop next-generation cancer immuno-oncology therapies, mainly focused on targeting of T-cells and myeloid cells, in order to improve the efficacy and increase the response rate in cancer patients. Bioinformatical analyses will be central for the research but depending on project progression, there will be possibilities to perform research from target discovery, based e.g. on transcriptomic studies, to functional in vitro studies and beyond, using antibodies developed against identified targets.
The research group and the department The post-doc position is within the research group of Assoc. Prof. Kristina Lundberg, who has a strong network of national and international collaborators among both basic science and clinical researchers. Kristina Lundberg is furthermore associated with CREATE Health, a Strategic Center for Translational Cancer Research (www.createhealth.lth.se) with a track record for rapid implementation of results from cancer research into clinical applications.
The research group is part of the Department of Immunotechnology with research spanning from advanced technology developments to biomedical research. Main research areas include oncology, hypersensitivity and antibody engineering. Advanced technologies are employed within the department including genomics and transcriptomics, large-scale mass spectrometry-based proteomics, affinity proteomics, phage display, and associated bioinformatics. In addition, we provide genomics and proteomics services, and our antibody development platform has been integrated into SciLifeLab’s Drug Discovery and Development Platform. The department is also responsible for several student courses and we offer high quality education at undergraduate and postgraduate level.
The department of Immunotechnology has a strong history of entrepreneurship and several companies have derived from the department. Additionally, the department is part of the CanFaster PhD program, a four-year doctoral program co-funded by EU, within cancer research and entrepreneurship. The application of advanced technologies to solve complex biomedical challenges has taken the department to the forefront in several research areas.
For further information and to apply for the position, please click here.
We are always seeking to recruit exceptional researchers at all career stages
The Department of Immunotechnology, performing world leading research in the field of applied immunology and has a long history of innovation driven research. The main research areas are oncology, allergy, autoimmunity, neurobiology, and antibody engineering. Our research employs advanced technologies including different types of microarray technologies (affinity proteomics), phage display, genomics and transcriptomics, large-scale mass spectrometry-based proteomics, and associated bioinformatics. In addition, we provide genomics and proteomics services, and our antibody development platform has been integrated into SciLifeLab’s Drug Discovery and Development Platform.
We have thesis projects for Masters students within immunotechnology. Please, contact the PI responsible for the research group of interest for more details.
We are always interested in reviewing Ph.D. student applications. For further information and updates on the application process, please contact the PI responsible for the research group of interest.
We welcome applicants for postdoctoral fellowships to apply at any time. The Department of Immunotechnology provides an advanced environment for scientists with experience in antibody technology, mass spectrometry, genomics and transcriptomics, large-scale mass spectrometry-based proteomics, different types of microarray technologies (affinity proteomics), phage display, and associated bioinformatics. In particular, we encourage people with experience in immunology, mass spectrometry, array technology, applied science and more patient oriented research (or with a strong motivation to learn the other discipline) to apply.
For more information please contact the PI responsible for the research group of interest.
Several groups at the Department of Immunotechnology is part of the research net-work, CREATE Health, with a focus on cancer research. One of the main objectives of CREATE Health is to encourage interdisciplinary and collaborative research projects in order to develop and apply new strategies for better and earlier diagnosis as well as better treatment options for cancer patients.
-Not for the next generation, but for today´s.